Sarbajit Mukherjee, Chief of GI Medical Oncology at Miami Cancer Institute and Co-Chair of GI Clinical Trial Working Group at Hoosier Cancer Research Network, shared on X:
“The ASCO Living Guideline on Advanced Gastroesophageal Cancer is now published in Journal of Clinical Oncology.
Grateful to be included on the expert panel.”
Title: Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2
Authors: Manish A. Shah, Jacob S. Marzalik, Erin B. Kennedy, Dana Deighton, Zahra Hamedi, Minaxi Jhawer, Kunal C. Kadakia, Paola Montenegro, Sarbajit Mukherjee, Christopher Nevala-Plagemann, Anwaar Saeed, Bryan J. Schneider, Thomas Semrad, Kohei Shitara, Melani Vincelli, Lakshmi Rajdev.
Read The Full Article.
You can also read: Top Phase 3 Gastroesophageal Cancer Trials to Watch at ASCO 2026
